Jilin Aodong Pharmaceutical Group Co Ltd (000623) — Cash Flow-to-Debt Ratio
Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of CN¥112.12 Million could theoretically repay 0% of its total liabilities (CN¥3.76 Billion) in one year. See 000623 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Jilin Aodong Pharmaceutical Group Co Ltd across 27 annual periods. Also explore 000623 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jilin Aodong Pharmaceutical Group Co Ltd (1998–2024)
Year-by-year debt coverage analysis for Jilin Aodong Pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see market cap of Jilin Aodong Pharmaceutical Group Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.02x | CN¥59.48 Million | CN¥3.72 Billion | ▲ +12.0% |
| 2023 | 0.01x | CN¥68.06 Million | CN¥4.77 Billion | ▼ -83.7% |
| 2022 | 0.09x | CN¥423.86 Million | CN¥4.83 Billion | ▲ +8.8% |
| 2021 | 0.08x | CN¥324.85 Million | CN¥4.03 Billion | ▼ -21.0% |
| 2020 | 0.10x | CN¥390.41 Million | CN¥3.82 Billion | ▼ -9.7% |
| 2019 | 0.11x | CN¥379.46 Million | CN¥3.36 Billion | ▲ +11.0% |
| 2018 | 0.10x | CN¥347.64 Million | CN¥3.41 Billion | ▼ -47.7% |
| 2017 | 0.19x | CN¥256.49 Million | CN¥1.32 Billion | ▼ -14.5% |
| 2016 | 0.23x | CN¥333.81 Million | CN¥1.47 Billion | ▲ +32.0% |
| 2015 | 0.17x | CN¥388.03 Million | CN¥2.25 Billion | ▼ -33.7% |
| 2014 | 0.26x | CN¥288.83 Million | CN¥1.11 Billion | ▲ +87.5% |
| 2013 | 0.14x | CN¥201.22 Million | CN¥1.45 Billion | ▼ -38.5% |
| 2012 | 0.23x | CN¥272.40 Million | CN¥1.21 Billion | ▲ +105.3% |
| 2011 | 0.11x | CN¥108.30 Million | CN¥985.86 Million | ▼ -58.9% |
| 2010 | 0.27x | CN¥174.22 Million | CN¥652.43 Million | ▼ -24.6% |
| 2009 | 0.35x | CN¥213.03 Million | CN¥601.83 Million | ▼ -4.4% |
| 2008 | 0.37x | CN¥235.03 Million | CN¥634.74 Million | ▼ -28.3% |
| 2007 | 0.52x | CN¥384.69 Million | CN¥744.94 Million | ▲ +158.9% |
| 2006 | 0.20x | CN¥187.99 Million | CN¥942.62 Million | ▲ +21.5% |
| 2005 | 0.16x | CN¥136.26 Million | CN¥829.84 Million | ▼ -33.1% |
| 2004 | 0.25x | CN¥218.53 Million | CN¥890.13 Million | ▼ -0.2% |
| 2003 | 0.25x | CN¥147.65 Million | CN¥600.19 Million | ▲ +3630.4% |
| 2002 | -0.01x | CN¥-4.58 Million | CN¥656.68 Million | ▼ -101.9% |
| 2001 | 0.38x | CN¥138.76 Million | CN¥369.87 Million | ▲ +58.4% |
| 2000 | 0.24x | CN¥77.04 Million | CN¥325.19 Million | ▲ +0.8% |
| 1999 | 0.24x | CN¥110.18 Million | CN¥468.69 Million | ▲ +261.6% |
| 1998 | -0.15x | CN¥-30.90 Million | CN¥212.43 Million | — |